Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Moving to a World Beyond “ p < 0.05”
2019 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Congenital Heart Disease in the General Population
2007 Standout
Multiple Perspectives on Inference for Two Simple Statistical Scenarios
2019
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial
2008
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Thrombocytopenia in the Intensive Care Unit
1993
Cancer to bone: a fatal attraction
2011 Standout
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
2009
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors
2006
Contribution of Primary Care to Health Systems and Health
2005 Standout
Non-inferiority trials are unethical because they disregard patients' interests
2007
Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
2006 Standout
Osteoporosis: now and the future
2011 Standout
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Trials and Tribulations of Non-Inferiority
2005
Cardiac medication during pregnancy, data from the ROPAC
2014
Global nutrition transition and the pandemic of obesity in developing countries
2012 Standout
Metal–Organic Frameworks as Efficient Materials for Drug Delivery
2006 Standout
A review of waste management practices and their impact on human health
2009 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Sample size calculations in randomised trials: mandatory and mystical
2005
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
2009
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
2011
Platelets and the immune continuum
2011 Standout
Structure–function relationships of immunostimulatory polysaccharides: A review
2015 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Nanomedicines: From Bench to Bedside and Beyond
2016
Comparative studies on polyelectrolyte complexes and mixtures of chitosan–alginate and chitosan–carrageenan as prolonged diltiazem clorhydrate release systems
2003
Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan — a review
2006 Standout
The Kidney from Prenatal to Adult Life: Perinatal Programming and Reduction of Number of Nephrons during Development
2009
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
2005
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
2013
Modeling and comparison of dissolution profiles
2001 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Subgroup identification from randomized clinical trial data
2011
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Recursive partitioning for heterogeneous causal effects
2016 StandoutNobel
Flexible Porous Metal-Organic Frameworks for a Controlled Drug Delivery
2008 Standout
On The Assessment of Similarity of Drug Dissolution Profiles—A Simulation Study
1997
The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview
2003
Indirect comparisons of competing interventions
2005
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Statistical Issues on the FDA Conjugated Estrogen Tablets Bioequivalence Guidance
1996
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae
2010 Standout
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)
2008
Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation
2007
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials
2006
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
2011
Statistical comparison between dissolution profiles of drug products
1997
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Some essential considerations in the design and conduct of non-inferiority trials
2011
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Fucoidan: Structure and Bioactivity
2008 Standout
Adaptive Designs: Terminology and Classification
2006
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Statistical Evaluation of Similarity Factor f2 as a Criterion for Assessment of Similarity Between Dissolution Profiles
1997
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Yi Tsong being referenced
Mortality resulting from blood dyscrasias in the United States, 1984
1990
Utility and pitfalls of some statistical methods in active controlled clinical trials
2002
Assessing proarrhythmic potential of drugs when optimal studies are infeasible
2009
Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment
2003
Some fundamental issues with non‐inferiority testing in active controlled trials
2002
In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2
1998
Group sequential test strategies for superiority and non‐inferiority hypotheses in active controlled clinical trials
2001
A Stability Analysis of a Modified Version of the Chi-Square Ratio Statistic: Implications for Equivalence Testing of Aerodynamic Particle Size Distribution
2012
Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols: Part 2—Evaluation of a method for determining equivalence
2007
Tests for Equivalence or Noninferiority Between Two Proportions
2000
Statistical Assessment of Mean Differences between Two Dissolution Data Sets
1996
ISSUES RELATED TO SUBGROUP ANALYSIS IN CLINICAL TRIALS
2002
Statistical Issues On Objective, Design, And Analysis Of Noninferiority Active-controlled Clinical Trial
2003